Clinical Trial Details
EORTC-16006-30005
Back to Clinical Trials Database
Open label phase II of MEN-10755 administered every 3 weeks in patients with progressive hormone refractory prostate cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 27-Aug-2001 Date Step1 close: 17-Mar-2003 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 32 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00027781 |
| NCT number | NCT00027781 |
